| publication_uri | type | publication_title | year | doi | pmid | journal_uri |
| http://vivo.scripps.edu/individual/endnote69238 | AcademicArticle | High-sensitivity c-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: A substudy from the charisma trial | 2011 | 10.1136/hrt.2010.210419 | 21393433 | http://vivo.scripps.edu/individual/endnote239917 |
| http://vivo.scripps.edu/individual/endnote384871 | AcademicArticle | Effect of clopidogrel plus asa vs. Asa early after tia and ischaemic stroke: A substudy of the charisma trial | 2011 | 10.1111/j.1747-4949.2010.00535.x | 21205234 | http://vivo.scripps.edu/individual/endnote108453 |
| http://vivo.scripps.edu/individual/endnote298521 | AcademicArticle | Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients a prespecified substudy of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (charisma) trial | 2010 | 10.1161/strokeaha.110.586727 | 20595658 | http://vivo.scripps.edu/individual/endnote303530 |
| http://vivo.scripps.edu/individual/endnote41094 | AcademicArticle | Aspirin to prevent cardiovascular disease: The association of aspirin dose and clopidogrel with thrombosis and bleeding | 2009 | 10.7326/0003-4819-150-6-200903170-00006 | 19293071 | http://vivo.scripps.edu/individual/endnote317144 |
| http://vivo.scripps.edu/individual/endnote188159 | AcademicArticle | Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (charisma) study | 2009 | 10.1016/j.ahj.2008.08.031 | 19332192 | http://vivo.scripps.edu/individual/endnote50170 |
| http://vivo.scripps.edu/individual/endnote73086 | AcademicArticle | The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease | 2009 | 10.1093/eurheartj/ehp037 | 19233855 | http://vivo.scripps.edu/individual/endnote137021 |
| http://vivo.scripps.edu/individual/endnote221528 | AcademicArticle | Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: Subgroup analysis of the charisma randomized trial | 2008 | 10.1159/000118380 | 18303254 | http://vivo.scripps.edu/individual/endnote89261 |
| http://vivo.scripps.edu/individual/endnote296485 | AcademicArticle | Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid determinants and effect on cardiovascular risk | 2008 | 10.1161/circulationaha.108.768283 | 18838564 | http://vivo.scripps.edu/individual/endnote329477 |
| http://vivo.scripps.edu/individual/endnote95086 | AcademicArticle | Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the charisma trial | 2007 | 10.1016/j.jacc.2007.03.025 | 17498584 | http://vivo.scripps.edu/individual/endnote242173 |
| http://vivo.scripps.edu/individual/endnote247642 | AcademicArticle | Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events | 2006 | 10.1056/NEJMoa060989 | 16531616 | http://vivo.scripps.edu/individual/endnote83648 |
| http://vivo.scripps.edu/individual/endnote120017 | AcademicArticle | A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial | 2005 | 10.1016/j.ahj.2005.03.017 | 16169314 | http://vivo.scripps.edu/individual/endnote50170 |
